Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
出版年份 2018 全文链接
标题
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 29, Issue 4, Pages 924-930
出版商
Oxford University Press (OUP)
发表日期
2018-01-06
DOI
10.1093/annonc/mdy004
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Overall response rate (ORR) in STEAM, a randomized, open-label, phase 2 trial of sequential and concurrent FOLFOXIRI-bevacizumab (BEV) vs FOLFOX-BEV for the first-line (1L) treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC).
- (2016) Johanna C. Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer: net survival and cause-specific survival rates after multiple imputation
- (2015) Adeline Morisot et al. BMC Medical Research Methodology
- FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
- (2015) Chiara Cremolini et al. LANCET ONCOLOGY
- Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis
- (2015) Hao Cheng et al. Scientific Reports
- Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
- (2014) Wei-Kai Xiao et al. BMC CANCER
- Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
- (2014) Fotios Loupakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Australian translational Study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT]
- (2013) Stephen Clarke et al. BMC CANCER
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
- (2013) Suee Lee et al. BMC CANCER
- Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis
- (2013) Mu-Xing Li et al. INTERNATIONAL JOURNAL OF CANCER
- Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature
- (2012) Alexander Stein et al. BMC CANCER
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
- (2012) Takashi Motomura et al. JOURNAL OF HEPATOLOGY
- Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy
- (2012) Manabu Kaneko et al. ONCOLOGY
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
- (2011) W Chua et al. BRITISH JOURNAL OF CANCER
- Neutrophil-Lymphocyte Ratio as a Predictor of Adverse outcomes of Acute Pancreatitis
- (2011) Basem Azab et al. PANCREATOLOGY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Cancer and Inflammation: Implications for Pharmacology and Therapeutics
- (2010) F Balkwill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Editorial: In this Issue
- (2010) Adrian Bot INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
- (2009) Yoji Kishi et al. ANNALS OF SURGICAL ONCOLOGY
- Systemic inflammation, nutritional status and survival in patients with cancer
- (2009) Donald C McMillan CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More